Adverse effects of systemic immunosuppression in keratolimbal allograft

Journal of Ophthalmology

Volumn 2012, Issue , 2012, Pages

  Krakauer, M ^a   Welder, J D ^a   Pandya, H K ^a   Nassiri, N ^a   Djalilian, A R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873814210     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2012/576712     Document Type: Article

References (15)

1. Kim J. Y., Djalilian A. R., Schwartz G. S., Holland E. J., Ocular surface reconstruction: limbal stem cell transplantation. Ophthalmology Clinics of North America 2003 16 1 67 77 2-s2.0-0345074106 10.1016/S0896-1549(02)00107-4 (Pubitemid 36384127)
2. Holland E. J., Djalilian A. R., Schwartz G. S., Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 2003 110 1 125 130 2-s2.0-0037226810 10.1016/S0161-6420(02)01451-3 (Pubitemid 36068737)
3. Ekberg H., Tedesco-Silva H., Demirbas A., Vítko Š.., Nashan B., Gürkan A., Margreiter R., Hugo C., Grinyó J. M., Frei U., Vanrenterghem Y., Daloze P., Halloran P. F., Reduced exposure to calcineurin inhibitors in renal transplantation. The New England Journal of Medicine 2007 357 25 2562 2575 2-s2.0-37349034394 10.1056/NEJMoa067411 (Pubitemid 350294223)
4. Denton M. D., Magee C. C., Sayegh M. H., Immunosuppressive strategies in transplantation. The Lancet 1999 353 9158 1083 1091 2-s2.0-0033608835 10.1016/S0140-6736(98)07493-5 (Pubitemid 29149926)
5. Biber J. M., Skeens H. M., Neff K. D., Holland E. J., eholland@fuse.net The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea 2011 30 7 765 771 10.1097/ICO.0b013e318201467c
6. Alloway R. R., Mogilishetty G., Cole L., Ocular surface transplant recipients experience fewer immunosuppression complications than renal transplant recipients: implications for facial and composite tissue transplantation. American Journal of Transplantation 2007 455 266
7. Liang L., Sheha H., Tseng S. C. G., Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Archives of Ophthalmology 2009 127 11 1428 1434 2-s2.0-70449720867 10.1001/archophthalmol.2009.263
8. Kempen J. H., Daniel E., Dunn J. P., Foster C. S., Gangaputra S., Hanish A., Helzlsouer K. J., Jabs D. A., Kaçmaz R. O., Levy-Clarke G. A., Liesegang T. L., Newcomb C. W., Nussenblatt R. B., Pujari S. S., Rosenbaum J. T., Suhler E. B., Thorne J. E., Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. British Medical Journal 2009 339, article b2480 2-s2.0-68149178506 10.1136/bmj.b2480
9. Kaçmaz R. O., Kempen J. H., Newcomb C., Daniel E., Gangaputra S., Nussenblatt R. B., Rosenbaum J. T., Suhler E. B., Thorne J. E., Jabs D. A., Levy-Clarke G. A., Foster C. S., Cyclosporine for ocular inflammatory diseases. Ophthalmology 2010 117 3 576 584 2-s2.0-77049113738 10.1016/j.ophtha.2009.08.010
10. Daniel E., Thorne J. E., Newcomb C. W., Pujari S. S., Kaçmaz R. O., Levy-Clarke G. A., Nussenblatt R. B., Rosenbaum J. T., Suhler E. B., Foster C. S., Jabs D. A., Kempen J. H., Mycophenolate mofetil for ocular inflammation. American Journal of Ophthalmology 2010 149 3 423 e2 2-s2.0-76749162797 10.1016/j.ajo.2009.09.026
11. Joseph A., Raj D., Shanmuganathan V., Powell R. J., Dua H. S., Tacrolimus immunosuppression in high-risk corneal grafts. British Journal of Ophthalmology 2007 91 1 51 55 2-s2.0-33846233032 10.1136/bjo.2006.097428 (Pubitemid 46094009)
12. Reinhard T., Reis A., Böhringer D., Malinowski M., Voiculescu A., Heering P., Godehardt E., Sundmacher R., Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology 2001 239 5 367 372 2-s2.0-0034948383 (Pubitemid 32600194)
13. Poon A. C., Forbes J. E., Dart J. K. G., Subramaniam S., Bunce C., Madison P., Ficker L. A., Tuft S. J., Gartry D. S., Buckley R. J., Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study. British Journal of Ophthalmology 2001 85 12 1464 1469 2-s2.0-0035679066 10.1136/bjo.85.12.1464 (Pubitemid 34032915)
14. Reinhard T., Spelsberg H., Henke L., Kontopoulos T., Enczmann J., Wernet P., Berschick P., Sundmacher R., Böhringer D., Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology 2004 111 4 775 782 2-s2.0-1842423155 10.1016/j.ophtha.2003.07.013 (Pubitemid 38429676)
15. Spelsberg H., Reinhard T., Henke L., Berschick P., Sundmacher R., Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results. Ophthalmology 2004 111 8 1528 1533 2-s2.0-3442891481 10.1016/j.ophtha.2004.01. 030 (Pubitemid 39030807)